167 related articles for article (PubMed ID: 2543278)
1. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1.
Ellis MN; Waters R; Hill EL; Lobe DC; Selleseth DW; Barry DW
Antimicrob Agents Chemother; 1989 Mar; 33(3):304-10. PubMed ID: 2543278
[TBL] [Abstract][Full Text] [Related]
2. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
Sakuma S; Yamamoto M; Kumano Y; Mori R
Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
4. Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice.
Ellis MN; Martin JL; Lobe DC; Johnsrude JD; Barry DW
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():95-101. PubMed ID: 3025159
[TBL] [Abstract][Full Text] [Related]
5. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.
Martin JL; Ellis MN; Keller PM; Biron KK; Lehrman SN; Barry DW; Furman PA
Antimicrob Agents Chemother; 1985 Aug; 28(2):181-7. PubMed ID: 3010836
[TBL] [Abstract][Full Text] [Related]
6. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Field HJ; Lay E
Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
Collins P; Ellis MN
J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
[TBL] [Abstract][Full Text] [Related]
8. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.
Hill EL; Hunter GA; Ellis MN
Antimicrob Agents Chemother; 1991 Nov; 35(11):2322-8. PubMed ID: 1666496
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.
Sibrack CD; Gutman LT; Wilfert CM; McLaren C; St Clair MH; Keller PM; Barry DW
J Infect Dis; 1982 Nov; 146(5):673-82. PubMed ID: 6290575
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
Christophers J; Sutton RN
J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.
Erlich KS; Mills J; Chatis P; Mertz GJ; Busch DF; Follansbee SE; Grant RM; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):293-6. PubMed ID: 2536136
[No Abstract] [Full Text] [Related]
15. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
16. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
17. Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.
Ellis MN; Lobe DC; Spector T
Antimicrob Agents Chemother; 1989 Oct; 33(10):1691-6. PubMed ID: 2556074
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase.
Parker AC; Craig JI; Collins P; Oliver N; Smith I
Lancet; 1987 Dec; 2(8573):1461. PubMed ID: 2892018
[No Abstract] [Full Text] [Related]
19. Uptake of [125I]iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir.
Van Dyke RB; Connor JD
J Infect Dis; 1985 Dec; 152(6):1206-11. PubMed ID: 2999258
[TBL] [Abstract][Full Text] [Related]
20. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
